CVS

Opinion: Top 2 takeaways from UBS Global Healthcare ConferenceThe conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Is Amazon a Threat to Traditional Drug Retailers?
Is Amazon a Threat to Traditional Drug Retailers?Amazon has massive resources, but it may struggle to enter the PBM marketplace.
Express Scripts Lowers Drug Prices For Some Patients
Express Scripts Lowers Drug Prices For Some PatientsHow Inside Rx could save patients money.
Drug chains, ASHP Support Anti-Price Gouging Campaign
Drug chains, ASHP Support Anti-Price Gouging CampaignA new campaign takes aim at drug prices, but is it the right approach?
Consumers buy fewer cigarettes after CVS stops selling themAfter CVS, the large retail pharmacy chain, stopped selling cigarettes in its stores, many consumers who used to buy their smokes at CVS simply bought fewer cigarettes and presumably smoked less.
CVS Health Names New COO
CVS Health Names New COOJonathan C. Roberts is named Executive Vice President and COO.
Four critical components for successful, value-based pharma contractsDespite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.
Pharmacists respond: Is CVS’ acquisition of Target pharmacies a good thing?Does this consolidation bode well for pharmacists? We asked pharmacists across the country to weigh in.
CVS launches med sync toolCVS Health recently introduced a new pharmacy service, ScriptSync, designed to enable patients with multiple Rxs to pick them up during one visit to the pharmacy.
CVS, hospitals undertake naloxone pharmacy studyResearchers plan to study the best way to deploy pharmacy-based naloxone rescue kits to help prevent opioid overdoses and deaths.